Eisai Co., Ltd.
Healthcare & Life Sci
Company overview
Eisai is a Japanese pharmaceutical company that discovers, develops, manufactures and sells medicines, including prescription drugs and over-the-counter products. LEQEMBI treats early-stage Alzheimer's disease. Lenvima treats endometrial carcinoma, Halaven is used against cancer, and Fycompa treats epilepsy. The company has about 10,000 employees, with about 1,500 working in research. Eisai is based in Tokyo, Japan. Eisai Co., Ltd. is a top-tier H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Tokyo, Japan